# Hyperfine Announces European Launch of Next-Generation Swoop® System
Canonical URL: https://biopharmsignal.com/news/HYPR/hyperfine-announces-european-launch-of-next-generation-swoop-system-eb9cfb69
Ticker: HYPR
Company: Hyperfine
Source: Hyperfine
Published: 2026-07-01 12:15 EST
Original Source URL: https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-announces-european-launch-next-generation-swoopr
## Summary

Hyperfine has initiated the launch of the next-generation Swoop® system in European markets, beginning the global expansion of its most advanced portable MRI technology. GUILFORD, Conn. --(BUSINESS WIRE)--Jul. 1, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company

## Article Body
Hyperfine has initiated the launch of the next-generation Swoop® system in European markets, beginning the global expansion of its most advanced portable MRI technology. GUILFORD, Conn. --(BUSINESS WIRE)--Jul. 1, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company
## Recent Company News
- 2026-07-01 12:15 EST — [Hyperfine Announces European Launch of Next-Generation Swoop® System](https://biopharmsignal.com/news/HYPR/hyperfine-announces-european-launch-of-next-generation-swoop-system-eb9cfb69) — Source: Hyperfine
- 2026-06-25 13:46 EST — [Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care](https://biopharmsignal.com/news/HYPR/hyperfine-forms-global-neurosurgery-advisory-council-to-support-expansion-of-portable-mri-in-neurosurgical-care) — Source: Hyperfine
- 2026-06-25 13:46 EST — [Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care](https://biopharmsignal.com/news/HYPR/hyperfine-swoopr-system-scan-volume-in-the-united-states-hits-record-milestones-across-multiple-sites-of-care) — Source: Hyperfine
- 2026-06-25 13:46 EST — [Hyperfine to Join Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes) — Source: Hyperfine
- 2026-06-25 13:46 EST — [Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments](https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments) — Source: Hyperfine
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)